Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study

MLA

Nicola Capasso, et al. “Ocrelizumab Effect on Humoral and Cellular Immunity in Multiple Sclerosis and Its Clinical Correlates: A 3-Year Observational Study.” Journal of Neurology, vol. 270, Sept. 2022, pp. 272–82. EBSCOhost, https://doi.org/10.1007/s00415-022-11350-1.

APA

Nicola Capasso, Raffaele Palladino, Vincenza Cerbone, Antonio Luca Spiezia, Bianca Covelli, Antonia Fiore, Roberta Lanzillo, Antonio Carotenuto, Maria Petracca, Lucia Stanziola, Giulia Scalia, Vincenzo Brescia Morra, & Marcello Moccia. (2022). Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study. Journal of Neurology, 270, 272–282. https://doi.org/10.1007/s00415-022-11350-1

Chicago

Nicola Capasso, Raffaele Palladino, Vincenza Cerbone, Antonio Luca Spiezia, Bianca Covelli, Antonia Fiore, Roberta Lanzillo, et al. 2022. “Ocrelizumab Effect on Humoral and Cellular Immunity in Multiple Sclerosis and Its Clinical Correlates: A 3-Year Observational Study.” Journal of Neurology 270 (September): 272–82. doi:10.1007/s00415-022-11350-1.